Epithelial-mesenchymal transition (EMT) plays an important role in renal tubulointerstitial fibrosis and TGF-␤1 is

Abstract. Diabetic nephropathy is characterized by excessive deposition of extracellular matrix (ECM) in the kidney. TGF-␤1 has been identified as the key mediator of ECM accumulation in diabetic kidney. High glucose induces TGF-␤1 in glomerular mesangial and tubular epithelial cells and in diabetic kidney. Antioxidants inhibit high glucoseinduced TGF-␤1 and ECM expression in glomerular mesangial and tubular epithelial cells and ameliorate features of diabetic nephropathy, suggesting that oxidative stress plays an important role in diabetic renal injury. High glucose induces intracellular reactive oxygen species (ROS) in mesangial and tubular epithelial cells. High glucose-induced ROS in mesangial cells can be effectively blocked by inhibition of protein kinase C (PKC), NADPH oxidase, and mitochondrial electron transfer chain complex I, suggesting that PKC, NADPH oxidase, and mitochondrial metabolism all play a role in high glucoseinduced ROS generation. Advanced glycation end products, TGF-␤1, and angiotensin II can also induce ROS generation and may amplify high glucose-activated signaling in diabetic kidney. Both high glucose and ROS activate signal transduction cascade (PKC, mitogen-activated protein kinases, and janus kinase/signal transducers and activators of transcription) and transcription factors (nuclear factor-B, activated protein-1, and specificity protein 1) and upregulate TGF-␤1 and ECM genes and proteins. These observations suggest that ROS act as intracellular messengers and integral glucose signaling molecules in diabetic kidney. Future studies elucidating various other target molecules activated by ROS in renal cells cultured under high glucose or in diabetic kidney will allow a better understanding of the final cellular responses to high glucose. Diabetic nephropathy is characterized by excessive deposition of extracellular matrix (ECM) in the kidney, leading to glomerular mesangial expansion and tubulointerstitial fibrosis. Clinical studies (1,2) have demonstrated that high blood glucose is the main determinant of initiation and progression of diabetic vascular complications including nephropathy. High glucose induces reactive oxygen species (ROS) (3,4) and upregulates TGF-␤1 (5,6) and ECM (5-7) expression in the glomerular mesangial cells. Exogenous hydrogen peroxide (H 2 O 2 ) or H 2 O 2 continuously generated by glucose oxidase (GO) also upregulates TGF-␤1 and fibronectin expression in mesangial cells (4,8) and fibronectin in tubular epithelial cells (9). Finally, antioxidants effectively inhibit high glucose-and H 2 O 2 -induced TGF-␤1 and fibronectin upregulation (4,8,9 -11), thus providing evidence that ROS play an important role in high glucose-induced renal injury. ROS-regulated signaling pathways leading to final renal cellular responses in diabetic kidney are not entirely clear, however.In this article, we review the mechanisms of high glucoseinduced ROS generation and ROS-induced activation of signal transduction cascade and transcription factors and overexpression of genes and pr...

Reactive oxygen species as glucose signaling molecules in mes-stress is defined as a tissue injury induced by increase in angial cells cultured under high glucose.reactive oxygen species (ROS) such as hydrogen perox-Background. Oxidative stress is one of the important mediaide (H 2 O 2 ), superoxide anion (O 2 •Ϫ ), and hydroxyl radical tors of vascular complications in diabetes including nephrop-( • OH) and is one of the proposed mechanisms involved athy. High glucose (HG) generates reactive oxygen species in diabetic complications [3][4][5]. A pathogenic role of (ROS) as a result of glucose auto-oxidation, metabolism, and formation of advanced glycosylation end products. The concept

Excessive accumulation of extracellular matrix (ECM) in the kidneys and epithelial-to-mesenchymal transition (EMT) of renal tubular epithelial cells contributes to the renal fibrosis that is associated with diabetic nephropathy. Histone deacetylase (HDAC) determines the acetylation status of histones and thereby controls the regulation of gene expression. This study examined the effect of HDAC inhibition on renal fibrosis induced by diabetes or transforming growth factor (TGF)-beta1 and determined the role of reactive oxygen species (ROS) as mediators of HDAC activation. In streptozotocin (STZ)-induced diabetic kidneys and TGF-beta1-treated normal rat kidney tubular epithelial cells (NRK52-E), we found that trichostatin A, a nonselective HDAC inhibitor, decreased mRNA and protein expressions of ECM components and prevented EMT. Valproic acid and class I-selective HDAC inhibitor SK-7041 also showed similar effects in NRK52-E cells. Among the six HDACs tested (HDAC-1 through -5 and HDAC-8), HDAC-2 activity significantly increased in the kidneys of STZ-induced diabetic rats and db/db mice and TGF-beta1-treated NRK52-E cells. Levels of mRNA expression of fibronectin and alpha-smooth muscle actin were decreased, whereas E-cadherin mRNA was increased when HDAC-2 was knocked down using RNA interference in NRK52-E cells. Interestingly, hydrogen peroxide increased HDAC-2 activity, and the treatment with an antioxidant, N-acetylcysteine, almost completely reduced TGF-beta1-induced activation of HDAC-2. These findings suggest that HDAC-2 plays an important role in the development of ECM accumulation and EMT in diabetic kidney and that ROS mediate TGF-beta1-induced activation of HDAC-2.

The present data demonstrate that high glucose up-regulates TGF-beta 1 and FN synthesis by HPMC, and that this high glucose-induced up-regulation is largely mediated by PKC. These results suggest that activation of PKC by high glucose in conventional PD solutions may constitute an important signal for activation of HPMC, leading to progressive accumulation of extracellular matrix and eventual peritoneal fibrosis.